Molecular mechanisms

分子机制
  • 文章类型: Journal Article
    莫斯卡蒂林,一种来自石斛属的双苄基衍生物,传统上一直用于中药。最近的研究表明,由于其多种药理特性,其作为一种强大的抗癌剂的潜力。这篇综述旨在巩固目前对moscatilin抗癌机制的研究。结构-活动关系,和治疗潜力,以评估其临床应用的可行性。在PubMed/MedLine进行了文献检索,Scopus,和WebofScience。搜索的重点是“癌症”,\"\"moscatilin,\"\"抗癌,\"\"生物活性,\"\"石斛,“和”药理学特性。“分子机制的相关研究,临床前和临床疗效,和生物利用度进行了审查。Moscatilin在肺部表现出显著的抗癌作用,乳房,结直肠,和胰腺癌。它通过JNK/SAPK途径诱导细胞凋亡,抑制细胞增殖,并抑制转移。结构-活性关系研究表明,酚基和二碳桥对其功效至关重要。此外,moscatilin显示出良好的生物利用度和良好的安全性,对健康细胞毒性低。Moscatilin展示了作为抗癌剂的巨大潜力,靶向多种癌症进展途径。进一步的临床试验对于确认其在人类中的治疗功效和安全性至关重要。
    Moscatilin, a bibenzyl derivative from the Dendrobium genus, has been traditionally used in Chinese medicine. Recent studies suggest its potential as a powerful anticancer agent due to its diverse pharmacological properties.This review aims to consolidate current research on moscatilin\'s anticancer mechanisms, structure-activity relationships, and therapeutic potential to assess its viability for clinical use. A literature search was performed in PubMed/MedLine, Scopus, and Web of Science.The search focused on \"cancer,\" \"moscatilin,\" \"anticancer,\" \"bioactivity,\" \"dendrobium,\" and \"pharmacological properties.\" Relevant studies on molecular mechanisms, preclinical and clinical efficacy, and bioavailability were reviewed. Moscatilin exhibits significant anticancer effects in lung, breast, colorectal, and pancreatic cancers. It induces apoptosis via the JNK/SAPK pathway, inhibits cell proliferation, and suppresses metastasis. Structure-activity relationship studies reveal that phenolic groups and a two-carbon bridge are crucial for its efficacy. Additionally, moscatilin shows good bioavailability and a favorable safety profile, with low toxicity to healthy cells. Moscatilin demonstrates considerable potential as an anticancer agent, targeting multiple cancer progression pathways. Further clinical trials are essential to confirm its therapeutic efficacy and safety in humans.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    水稻种子的可贮性对于确保灵活的种植选择至关重要,农业种子安全,全球食品安全。随着全球气候变化的加剧和农业生产条件的不断波动,提高水稻种子的耐贮性变得尤为重要。种子耐贮性是一个复杂的数量性状,受遗传和环境因素共同调控。本文综述了水稻种子耐贮性的主要调控机制,包括种子储存蛋白的积累,晚期胚胎发生丰富(LEA)蛋白,热休克蛋白,糖信号,赤霉素和脱落酸的荷尔蒙调节,以及泛素化途径的作用。此外,本文探讨了利用野生稻基因提高耐贮性,分子标记辅助选择,和CRISPR/Cas9等基因编辑技术在水稻育种中的应用。通过提供全面的科学依据和实践指导,这项审查旨在促进水稻品种的发展,以提高耐候性,以满足不断变化的农业需求。
    The storability of rice seeds is crucial for ensuring flexible planting options, agricultural seed security, and global food safety. With the intensification of global climate change and the constant fluctuations in agricultural production conditions, enhancing the storability of rice seeds has become particularly important. Seed storability is a complex quantitative trait regulated by both genetic and environmental factors. This article reviews the main regulatory mechanisms of rice seed storability, including the accumulation of seed storage proteins, late embryogenesis abundant (LEA) proteins, heat shock proteins, sugar signaling, hormonal regulation by gibberellins and abscisic acid, and the role of the ubiquitination pathway. Additionally, this article explores the improvement of storability using wild rice genes, molecular marker-assisted selection, and gene editing techniques such as CRISPR/Cas9 in rice breeding. By providing a comprehensive scientific foundation and practical guidance, this review aims to promote the development of rice varieties with enhanced storability to meet evolving agricultural demands.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在未来的再生医学中,远红外辐射(FIR)可能是光学治疗的重要组成部分。许多研究已经证实或验证了FIR在各种疾病中的疗效和安全性,受益于对FIR机制的新见解和许多应用程序的卓越性能。然而,对FIR的生物学效应和治疗参数缺乏共识限制了其在临床中的实际应用。在这次审查中,定义,特点,并系统地阐述了FIR的基本原理。我们概述了FIR的治疗参数,包括波长范围,功率密度,辐照时间,和距离。此外,生物效应,潜在的分子机制,讨论了FIR的临床前和临床应用。此外,本文介绍了FIR的未来发展和应用。通过应用最佳治疗参数,FIR可以影响各种细胞,动物模型,和病人,引发不同的潜在机制,并为许多疾病提供治疗潜力。FIR可能是一种优越的替代品,在未来的再生医学中具有广阔的应用前景。
    In future regenerative medicine, far-infrared radiation (FIR) may be an essential component of optical therapy. Many studies have confirmed or validated the efficacy and safety of FIR in various diseases, benefiting from new insights into FIR mechanisms and the excellent performance of many applications. However, the lack of consensus on the biological effects and therapeutic parameters of FIR limits its practical applications in the clinic. In this review, the definition, characteristics, and underlying principles of the FIR are systematically illustrated. We outline the therapeutic parameters of FIR, including the wavelength range, power density, irradiation time, and distance. In addition, the biological effects, potential molecular mechanisms, and preclinical and clinical applications of FIR are discussed. Furthermore, the future development and applications of FIR are described in this review. By applying optimal therapeutic parameters, FIR can influence various cells, animal models, and patients, eliciting diverse underlying mechanisms and offering therapeutic potential for many diseases. FIR could represent a superior alternative with broad prospects for application in future regenerative medicine.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    尽管由于可能的长期问题,神经胶质瘤的传统治疗方法正在减弱,来自自然界的物质的治愈可能性已经在科学界重新点燃。这些天然物质,常见于水果和蔬菜,被认为是药物的潜在替代品,正如它们在先前的研究中所显示的那样影响围绕癌症进展的通路,转移,入侵,和阻力。这篇综述将探讨不同天然成分的假定分子机制,比如小檗碱,姜黄素,咖啡,白藜芦醇,表没食子儿茶素-3-没食子酸酯,槲皮素,丹参酮,水飞蓟素,香豆素,还有番茄红素,关于神经胶质瘤的治疗。虽然含有这些化合物的均衡饮食的好处被广泛认可,研究这些天然产物治疗神经胶质瘤的功效还有相当大的余地。
    Despite the waning of traditional treatments for glioma due to possible long-term issues, the healing possibilities of substances derived from nature have been reignited in the scientific community. These natural substances, commonly found in fruits and vegetables, are considered potential alternatives to pharmaceuticals, as they have been shown in prior research to impact pathways surrounding cancer progression, metastases, invasion, and resistance. This review will explore the supposed molecular mechanisms of different natural components, such as berberine, curcumin, coffee, resveratrol, epigallocatechin-3-gallate, quercetin, tanshinone, silymarin, coumarin, and lycopene, concerning glioma treatment. While the benefits of a balanced diet containing these compounds are widely recognized, there is considerable scope for investigating the efficacy of these natural products in treating glioma.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    2型糖尿病(T2DM)是动脉粥样硬化(AS)的主要原因。然而,缺乏关于这两种疾病的共同分子机制的明确证据。本研究旨在探讨T2DM与AS之间关联的潜在机制。
    T2DM(GSE159984)和AS(GSE100927)的基因表达谱从基因表达综述获得,之后,重叠差异表达的基因鉴定,生物信息学富集分析,蛋白质-蛋白质相互作用网络的构建,并进行核心基因鉴定。我们使用受试者工作曲线分析证实了核心基因的判别能力。我们使用TRRUST数据库进一步鉴定了转录因子,以建立转录因子-mRNA调控网络。最后,分析了免疫浸润情况以及核心基因与差异浸润免疫细胞之间的相关性。
    在双胁迫条件下鉴定出总共27个重叠的差异表达基因。功能分析表明,免疫反应和转录调控可能参与潜在的发病机制。蛋白质-蛋白质相互作用网络解构后,外部数据集,和qRT-PCR实验验证,四个核心基因(IL1B,C1QA,CCR5和MSR1)被鉴定。ROC分析进一步显示了这些核心基因的可靠价值。四种常见的差异浸润性免疫细胞(B细胞,CD4+T细胞,调节性T细胞,基于免疫细胞浸润选择T2DM和AS数据集之间的M2巨噬细胞)。核心基因与普通差异免疫细胞之间存在显著相关性。此外,五个转录因子(RELA,NFκB1,JUN,YY1和SPI1)调节核心基因的转录使用上游基因调节因子分析来挖掘。
    在这项研究中,确定了T2DM和AS之间的共同靶基因和共同免疫浸润景观。五个转录因子之间的关系,四个核心基因,4种免疫细胞谱可能对理解T2DM并发AS的发病机制和治疗方向至关重要。
    UNASSIGNED: Type 2 diabetes mellitus (T2DM) is a major cause of atherosclerosis (AS). However, definitive evidence regarding the common molecular mechanisms underlying these two diseases are lacking. This study aimed to investigate the mechanisms underlying the association between T2DM and AS.
    UNASSIGNED: The gene expression profiles of T2DM (GSE159984) and AS (GSE100927) were obtained from the Gene Expression Omnibus, after which overlapping differentially expressed gene identification, bioinformatics enrichment analyses, protein-protein interaction network construction, and core genes identification were performed. We confirmed the discriminatory capacity of core genes using receiver operating curve analysis. We further identified transcription factors using TRRUST database to build a transcription factor-mRNA regulatory network. Finally, the immune infiltration and the correlation between core genes and differential infiltrating immune cells were analyzed.
    UNASSIGNED: A total of 27 overlapping differentially expressed genes were identified under the two-stress conditions. Functional analyses revealed that immune responses and transcriptional regulation may be involved in the potential pathogenesis. After protein-protein interaction network deconstruction, external datasets, and qRT-PCR experimental validation, four core genes (IL1B, C1QA, CCR5, and MSR1) were identified. ROC analysis further showed the reliable value of these core genes. Four common differential infiltrating immune cells (B cells, CD4+ T cells, regulatory T cells, and M2 macrophages) between T2DM and AS datasets were selected based on immune cell infiltration. A significant correlation between core genes and common differential immune cells. Additionally, five transcription factors (RELA, NFκB1, JUN, YY1, and SPI1) regulating the transcription of core genes were mined using upstream gene regulator analysis.
    UNASSIGNED: In this study, common target genes and co-immune infiltration landscapes were identified between T2DM and AS. The relationship among five transcription factors, four core genes, and four immune cells profiles may be crucial to understanding T2DM complicated with AS pathogenesis and therapeutic direction.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    脓毒症致心肌功能障碍(SIMD),也称为脓毒症诱发的心肌病(SICM),与死亡率显著增加有关。尽管其临床重要性,SIMD的有效疗法仍然难以捉摸,很大程度上是由于对其发病机制的理解不完全。在过去的五十年里,涉及动物模型和人体研究的研究强调了SICM的几种致病机制,然而,许多方面仍未探索。最初被认为主要由炎症细胞因子驱动,目前的研究表明,这些单独的心脏功能障碍的发展是不够的。最近的研究引起了人们对其他机制的关注,包括过量的一氧化氮产生,线粒体功能障碍,和钙稳态的紊乱,作为SICM的促成因素。新的临床证据强调了心肌水肿在SICM发病机制中的重要作用。尤其是其与感染性休克患者心脏重塑的关系。这篇综述综合了我们目前对SIMD/SICM的理解,关注心肌水肿对心脏功能障碍的贡献和缓激肽受体B1(B1R)在改变心肌微血管通透性中的关键作用,脓毒症心肌水肿发展的潜在关键参与者。此外,这篇综述简要总结了现有的治疗策略及其面临的挑战,并探讨了未来的研究方向。它强调需要更深入地了解SICM以开发更有效的治疗方法。
    Sepsis-induced myocardial dysfunction (SIMD), also known as sepsis-induced cardiomyopathy (SICM), is linked to significantly increased mortality. Despite its clinical importance, effective therapies for SIMD remain elusive, largely due to an incomplete understanding of its pathogenesis. Over the past five decades, research involving both animal models and human studies has highlighted several pathogenic mechanisms of SICM, yet many aspects remain unexplored. Initially thought to be primarily driven by inflammatory cytokines, current research indicates that these alone are insufficient for the development of cardiac dysfunction. Recent studies have brought attention to additional mechanisms, including excessive nitric oxide production, mitochondrial dysfunction, and disturbances in calcium homeostasis, as contributing factors in SICM. Emerging clinical evidence has highlighted the significant role of myocardial edema in the pathogenesis of SICM, particularly its association with cardiac remodeling in septic shock patients. This review synthesizes our current understanding of SIMD/SICM, focusing on myocardial edema\'s contribution to cardiac dysfunction and the critical role of the bradykinin receptor B1 (B1R) in altering myocardial microvascular permeability, a potential key player in myocardial edema development during sepsis. Additionally, this review briefly summarizes existing therapeutic strategies and their challenges and explores future research directions. It emphasizes the need for a deeper understanding of SICM to develop more effective treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    我们旨在探讨hsa-miR-141-3p和双特异性蛋白磷酸酶1(DUSP1)在子宫颈癌(UCC)中的异常表达状态及其相关机制。定量逆转录-聚合酶链反应(RT-qPCR)检测hsa-miR-141-3p的表达。进行免疫组织化学(IHC)染色以检查DUSP1在UCC中的表达。还获得基因芯片和RNA-seq数据集以评估表达水平。计算综合标准化平均差(SMD)以全面评估hsa-miR-141-3p在UCC组织中的表达状态。建立DUSP1过表达和hsa-miR-141-3p抑制HeLa细胞,和CCK-8Transwell,伤口愈合,细胞周期,并实施细胞凋亡测定。通过在线工具获得hsa-miR-141-3p的靶标,hsa-miR-141-3p和DUSP1的组合通过双荧光素酶报告基因试验进行验证。分析单细胞RNA-seq数据以探索不同细胞中的hsa-miR-141-3p和DUSP1。集成SMD为1.41(95%CI[0.45,2.38],p=0.0041),558个样品显示hsa-miR-141-3p在UCC组织中过度表达。合并的SMD为-1.06(95%CI[-1.45,-0.66],p<0.0001),1,268个样本表明DUSP1下调。抑制hsa-miR-141-3p可以上调DUSP1表达并抑制HeLa细胞的侵袭和转移。DUSP1的过表达会阻碍增殖,入侵,和迁移,促进细胞凋亡和G1期的分布。双荧光素酶报告基因测定验证了hsa-miR-141-3p和DUSP1的组合。此外,hsa-miR-141-3p的靶标主要富集在MAPK信号通路中,并在成纤维细胞和内皮细胞中被激活。目前的研究说明了hsa-miR-141-3p在UCC组织中的上调和DUSP1的下调。Hsa-miR-141-3p可通过靶向DUSP1促进UCC进展。
    We aimed to explore the aberrant expression status of hsa-miR-141-3p and dual-specificity protein phosphatase 1 (DUSP1) and their relative mechanisms in uterine cervical carcinoma (UCC).Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was conducted to detect the expression of hsa-miR-141-3p. Immunohistochemical (IHC) staining was performed to examine the expression of DUSP1 in UCC. Gene chips and RNA-seq datasets were also obtained to assess the expression level. Integrated standardized mean difference (SMD) was calculated to evaluate the expression status of hsa-miR-141-3p in UCC tissues comprehensively. DUSP1-overexpression and hsa-miR-141-3p-inhibition HeLa cells were established, and CCK-8, transwell, wound healing, cell cycle, and apoptosis assays were implemented. The targets of hsa-miR-141-3p were obtained with online tools, and the combination of hsa-miR-141-3p and DUSP1 was validated via dual-luciferase reporter assay. Single-cell RNA-seq data were analyzed to explore hsa-miR-141-3p and DUSP1 in different cells. An integrated SMD of 1.41 (95% CI[0.45, 2.38], p = 0.0041) with 558 samples revealed the overexpression of hsa-miR-141-3p in UCC tissues. And the pooled SMD of -1.06 (95% CI[-1.45, -0.66], p < 0.0001) with 1,268 samples indicated the downregulation of DUSP1. Inhibition of hsa-miR-141-3p could upregulate DUSP1 expression and suppress invasiveness and metastasis of HeLa cells. Overexpression of DUSP1 could hamper proliferation, invasion, and migration and boost apoptosis and distribution of G1 phase. The dual-luciferase reporter assay validated the combination of hsa-miR-141-3p and DUSP1. Moreover, the targets of hsa-miR-141-3p were mainly enriched in the MAPK signaling pathway and activated in fibroblasts and endothelial cells. The current study illustrated the upregulation of hsa-miR-141-3p and the downregulation of DUSP1 in UCC tissues. Hsa-miR-141-3p could promote UCC progression by targeting DUSP1.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    RNA依赖性RNA聚合酶(RdRP)从单链RNA(ssRNA)模板合成双链RNA(dsRNA)。在植物中,由RdRP产生的dsRNA可以进一步加工成具有不同长度的小干扰RNA(siRNA),范围从21到24个核苷酸(nt)。这些siRNA在各种生物过程中发挥关键作用,包括抗病毒反应,转座因子沉默,DNA甲基化,以及植物繁殖和发育的调节。最近的研究报道了在揭示植物RNA依赖性RNA聚合酶2(RDR2)的分子机制方面取得的重大进展,参与RNA指导的DNA甲基化(RdDM)途径的代表性RdRP。这些发现提供了RdRP功能原理的分子基础,并提供了对作物育种和抗病毒防御策略的潜在进步的见解。
    RNA-dependent RNA Polymerases (RdRPs) synthesize double-stranded RNA (dsRNA) from a single-stranded RNA (ssRNA) template. In plants, dsRNAs produced by RdRPs can be further processed into small interfering RNA (siRNAs) with different lengths, ranging from 21 to 24 nucleotides (nt). These siRNAs play a pivotal role in various biological processes, including antiviral responses, transposable elements silencing, DNA methylation, and the regulation of plant reproduction and development. Recent research has reported significant progress in uncovering the molecular mechanisms of plant RNA-DEPENDENT RNA POLYMERASE 2 (RDR2), a representative RdRP involved in the RNA-directed DNA methylation (RdDM) pathway. These discoveries provide a molecular basis underlying the principles of RdRP function and offer insights into potential advancements in crop breeding and antiviral defense strategies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    变应性鼻炎(AR)是一种常见的鼻黏膜炎症性疾病,由过敏原暴露引发,并以打喷嚏等症状为特征,鼻塞,瘙痒,还有鼻漏.这篇全面的综述旨在解开支撑AR的分子机制,探索从过敏原识别到慢性炎症和组织重塑的发病机制。该疾病的核心是免疫球蛋白E(IgE)介导的超敏反应,涉及关键的炎症介质和细胞参与者,如肥大细胞,嗜酸性粒细胞,和T细胞。遗传易感性和环境因素在易感性和疾病进展中也起着重要作用。AR的治疗策略多种多样,从通过抗组胺药和鼻用糖皮质激素缓解症状到更有针对性的方法,如过敏原特异性免疫疗法。新兴的治疗集中在新的分子途径,越来越重视个性化医疗以优化患者预后。尽管取得了进步,在充分理解AR的异质性和开发普遍有效的治疗方法方面仍然存在挑战。这篇综述综合了当前的知识,强调对AR的分子基础及其对临床实践的意义的关键见解。它强调了整合的必要性,多学科方法来提高治疗效果,并呼吁正在进行的研究,以解决尚未解决的问题,并探索AR管理的新领域。通过这种全面的综合,这篇综述旨在为未来的研究和临床策略提供信息和启发,最终改善受AR影响的个体的生活质量。
    Allergic rhinitis (AR) is a prevalent inflammatory disorder of the nasal mucosa, triggered by allergen exposure and characterized by symptoms such as sneezing, nasal congestion, itching, and rhinorrhea. This comprehensive review aims to unravel the molecular mechanisms underpinning AR, exploring the pathogenesis from allergen recognition to chronic inflammation and tissue remodelling. Central to the disease are immunoglobulin E (IgE)-mediated hypersensitivity reactions, involving key inflammatory mediators and cellular players such as mast cells, eosinophils, and T cells. Genetic predisposition and environmental factors also play significant roles in susceptibility and disease progression. Therapeutic strategies for AR are varied, ranging from symptomatic relief through antihistamines and nasal corticosteroids to more targeted approaches like allergen-specific immunotherapy. Emerging treatments focus on novel molecular pathways, with a growing emphasis on personalized medicine to optimize patient outcomes. Despite advancements, challenges remain in fully understanding the heterogeneity of AR and developing universally effective treatments. This review synthesizes current knowledge, highlighting critical insights into the molecular basis of AR and their implications for clinical practice. It underscores the need for integrated, multidisciplinary approaches to enhance therapeutic efficacy and calls for ongoing research to address unresolved questions and explore new frontiers in AR management. Through this comprehensive synthesis, the review aims to inform and inspire future research and clinical strategies, ultimately improving the quality of life for individuals affected by AR.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    糖尿病心肌病(DbCM)是2型糖尿病(T2DM)患者的常见并发症,其确切的发病机制仍有争议。假设慢性高血糖症和胰岛素抵抗激活了关键的细胞途径,这些途径负责心脏中的许多功能和解剖扰动。间质性炎症,氧化应激,心肌细胞凋亡,线粒体功能障碍,心脏代谢缺陷,心脏重塑,肥大和纤维化以及随之而来的收缩力受损是最常见的机制。表观遗传变化在这些关键途径的调节中也具有新兴作用。这篇综述的目的是强调对DbCM分子机制和靶向特定途径的新疗法的日益深入的了解。
    Diabetic cardiomyopathy (DbCM) is a common complication in individuals with type 2 diabetes mellitus (T2DM), and its exact pathogenesis is still debated. It was hypothesized that chronic hyperglycemia and insulin resistance activate critical cellular pathways that are responsible for numerous functional and anatomical perturbations in the heart. Interstitial inflammation, oxidative stress, myocardial apoptosis, mitochondria dysfunction, defective cardiac metabolism, cardiac remodeling, hypertrophy and fibrosis with consequent impaired contractility are the most common mechanisms implicated. Epigenetic changes also have an emerging role in the regulation of these crucial pathways. The aim of this review was to highlight the increasing knowledge on the molecular mechanisms of DbCM and the new therapies targeting specific pathways.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号